Trial Profile
A randomized, open label, phase II study of OSI-7904L versus 5-FU/LV [fluorouracil + folinic acid] as first-line treatment in patients with unresectable, locally advanced or metastatic adenocarcinoma of the biliary tract
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Sep 2007
Price :
$35
*
At a glance
- Drugs OVI 237 (Primary) ; Fluorouracil; Folinic acid
- Indications Biliary cancer
- Focus Therapeutic Use
- 04 Aug 2007 Final results have been published
- 09 Sep 2005 New trial record.